Summary: Idiopathic Intracranial Hypertension (IIH) • Increased intracranial pressure of an idiopathic nature • Treated with acetazolamide/weight loss + surgery as deemed necessary o Acetazolamide (Diamox) is an effective first-line therapy according to IIH Treatment Trial (IIHTT) -Lowers intracranial pressure -Treats vision loss and papilledema stemming from IIH IIH Patients and Treatment • Tend to be young, overweight females o Weight loss is preferred treatment • Acetazolamide is effective medical therapy o Normal dosage is 500 mg a day -IIHTT allows for dosage of up to 2-4 grams/day o Dosage limited by side effects -Paresthesias -Tingling in hands/feet -Metallic taste in mouth following consumption of carbonated beverages -Fatigue -Freq...
Idiopathic intracranial hypertension (IIH) is a potentially blinding disorder that typically affects...
The NORDIC IIH treatment trial established new standards regarding the use and dosing of acetazolami...
BACKGROUND The management of idiopathic intracranial hypertension focuses on reducing intracrania...
Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in...
Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in...
Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insu...
Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insu...
To examine the tolerability and adverse events reported in the Idiopathic Intracranial Hypertension ...
The cause of Idiopathic intracranial hypertension (IIH) remains unknown and no consensus exists on h...
Idiopathic intracranial hypertension (IIH) is a common and potentially blinding disorder that affect...
Idiopathic intracranial hypertension (IIH) is a potentially blinding disorder that typically affects...
Idiopathic intracranial hypertension (IIH) is a neurological disorder characterized by elevated intr...
Background: Idiopathic intracranial hypertension (IIH) is a condition with few effective management ...
WOS: 000249990000008PubMed ID: 17922725Objectives - To assess the efficacy of topiramate in the trea...
So I'm gonna be talking to you about some of the problems that we see with acetazolamide, known as D...
Idiopathic intracranial hypertension (IIH) is a potentially blinding disorder that typically affects...
The NORDIC IIH treatment trial established new standards regarding the use and dosing of acetazolami...
BACKGROUND The management of idiopathic intracranial hypertension focuses on reducing intracrania...
Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in...
Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in...
Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insu...
Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insu...
To examine the tolerability and adverse events reported in the Idiopathic Intracranial Hypertension ...
The cause of Idiopathic intracranial hypertension (IIH) remains unknown and no consensus exists on h...
Idiopathic intracranial hypertension (IIH) is a common and potentially blinding disorder that affect...
Idiopathic intracranial hypertension (IIH) is a potentially blinding disorder that typically affects...
Idiopathic intracranial hypertension (IIH) is a neurological disorder characterized by elevated intr...
Background: Idiopathic intracranial hypertension (IIH) is a condition with few effective management ...
WOS: 000249990000008PubMed ID: 17922725Objectives - To assess the efficacy of topiramate in the trea...
So I'm gonna be talking to you about some of the problems that we see with acetazolamide, known as D...
Idiopathic intracranial hypertension (IIH) is a potentially blinding disorder that typically affects...
The NORDIC IIH treatment trial established new standards regarding the use and dosing of acetazolami...
BACKGROUND The management of idiopathic intracranial hypertension focuses on reducing intracrania...